Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gencor Industries (GENC) Capital Expenditures (2016 - 2025)

Gencor Industries' Capital Expenditures history spans 16 years, with the latest figure at $973000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 205.02% year-over-year to $973000.0; the TTM value through Dec 2025 reached $2.6 million, up 230.01%, while the annual FY2025 figure was $2.0 million, 133.69% up from the prior year.
  • Capital Expenditures reached $973000.0 in Q4 2025 per GENC's latest filing, down from $1.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.3 million in Q3 2022 to a low of $12000.0 in Q1 2024.
  • Average Capital Expenditures over 5 years is $638250.0, with a median of $521500.0 recorded in 2023.
  • Peak YoY movement for Capital Expenditures: crashed 97.44% in 2024, then skyrocketed 1214.29% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $1.0 million in 2021, then decreased by 29.71% to $705000.0 in 2022, then plummeted by 48.09% to $366000.0 in 2023, then dropped by 12.84% to $319000.0 in 2024, then skyrocketed by 205.02% to $973000.0 in 2025.
  • Per Business Quant, the three most recent readings for GENC's Capital Expenditures are $973000.0 (Q4 2025), $1.0 million (Q3 2025), and $491000.0 (Q2 2025).